GMBC-DxInc. Revenue and Competitors

Detroit, MI USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GMBC-DxInc.'s estimated annual revenue is currently $155k per year.(i)
  • GMBC-DxInc.'s estimated revenue per employee is $155,000

Employee Data

  • GMBC-DxInc. has 1 Employees.(i)
  • GMBC-DxInc. grew their employee count by -75% last year.

GMBC-DxInc.'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.9M120%N/AN/A
#2
$2.6M34-56%$31.2MN/A
#3
$0.8M5-44%N/AN/A
#4
$1.9M24100%N/AN/A
#5
$6M39-11%N/AN/A
#6
$4M26-33%N/AN/A
#7
$1.9M120%N/AN/A
#8
$0.8M525%N/AN/A
#9
$14.6M948%N/AN/A
#10
$3.4M225%N/AN/A
Add Company

What Is GMBC-DxInc.?

Global Medical Business Catalysts-Diagnostics GMBC-Dx was conceived in early 2012 by its founders, Douglas Danne and Dennis Taschek. Our goal is simply stated; "defining pathways for International companies entering the regulated markets of in-vitro diagnostics in the United States, or the unregulated veterinary marketplace." We have found that the expertise needed initializing commercialization in the regulatory bound arena of clinical diagnostics is sorely lacking and misunderstood. We have created a copyrighted process for 510(k) attainment and tailoring business entry solutions for several clients needing introduction to the large US marketplace. We are also working concurrently with clients in the veterinary market. Please peruse our website to discover the five areas we have defined as strategic arms for our company. You will find detailed information under Products & Services. We know that through our experience and with our growing umbrella of global assoicates, we can help your company achieve its destiny.

keywords:N/A

N/A

Total Funding

1

Number of Employees

$155k

Revenue (est)

-75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M1-97%N/A
#2
$0.1M2-50%N/A
#3
$0.2M3-57%N/A
#4
$7.5M3-50%N/A
#5
$0.4M30%N/A